Low molecular weight heparin
In medicine, low molecular weight heparin (LMWH) is a class of medication used as an anticoagulant in diseases that feature thrombosis, as well as for prophylaxis in situations that lead to a high risk of thrombosis.
Its differences with unfractioned heparin are:
- No need for monitoring of the APTT coagulation parameter
- Possibly a smaller risk of bleeding
- Smaller risk of osteoporosis in long-time use
- Smaller risk of heparin-induced thrombocytopenia, a feared side-effect of heparin.
Makes of LMWHs include:
- Dalteparin (Fragmin®)
- Enoxaparin (Clexane® and Lovenox®)
- Nadroparin (Fraxiparin® and Fraxodi®)
- Tinzaparin
- Several others
This article is a stub. You can help BambooWeb by .
